Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Neutrophils are important for causing chronic itch in atopic dermatitis, and blocking the CXCR3 receptor may reduce this itch.

Neutrophils are key in causing chronic itch in atopic dermatitis, and blocking CXCR3 could reduce this itch.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Hair follicles help attract immune cells to the skin during stress.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.